Charles Gore, Chief Executive of the Hepatitis C UK Trust for his perceptive inputs from a consumer perspective. Megan Prictor and Sophie Hill, of the Cochrane Consumers and Communication Review Group ‐ for their support and comments on the design and co‐ordination of the review. Sandy Oliver, Editor, Cochrane Consumers and Communication Review Group ‐ for coordinating the editorial and peer‐reviewers' comments. Per Egil Kummervold, Per Hjortdal and Martin Jenssen for noticing the error in direction of change for the clinical outcomes in the original version of this review, and bringing this error to our attention. The entire Cochrane Consumers and Communication Review Group, Nick Royle, Chief Executive of the Cochrane Collaboration and Mike Clarke, Director of UK Cochrane Centre for their ongoing help and support after identification of the errors in the original review, and assistance with addressing these errors and their consequences. Two independent Cochrane statisticians for their thorough critique of the revised review. Richard Morris, Reader in Medical Statistics and Epidemiology in the Department of Primary Care and Population Sciences at University College London for acting as our internal independent statistical reviewer after the detection of the errors, and for advice on revising the analyses. The first version of the review was assessed by four editors of the Cochrane Consumers and Communication Review Group, and four external referees, including one consumer referee. The revised version was assessed by five editors of the Cochrane Consumers and Communication Review Group, a content expert, a consumer referee and two statisticians.